Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5427_Библиотеки_им_академика_М_И_Перельмана
.pdf
362 T. Tagami et al.
In one study, hydroxypropyl cellulose/Kollidon VA 64-based floating tablets
were prepared by FDM 3D printer. The Box-Behnken model was used for DoE,
and two DoEs were separately applied (Vo et al.
2020). The authors set several
factors of the printing structure in one DoE (shell thickness, top/bottom thickness,
infill density) to obtain the output (floating force and drug dissolution). Then,
they set the factors of tablet dimensions in another DoE (diameter, height, and
thickness) to obtain the same output. Good correlation between floating force and
drug dissolution of 3D printed tablets and printing parameter was successfully
obtained.
In another study, 3D printed mini-caplets containing baclofen were prepared
by FDM 3D printer, and the formulations were composed of PVA/sorbitol-based
filament (Palekar et al.
2019). The authors mentioned that medication errors with
children are often due to suboptimal efficacy because extemporaneous formulations
for children can be prepared by manipulating adult formulations. Dose adjustment
using 3D printing holds promise for addressing this problem. In this study, 3D
printed mini-caplets were prepared by changing parameters such as infill percentage
(30, 65, 100%) and pattern (hexagonal, sharkfill, linear, diamond), and then drug
dissolution was evaluated. The response surface plot against drug dissolution was
obtained by using DoE (3
2
full functional design). The results showed that the size
and infill density could affect the drug dissolution positively.
Diclofenac-loaded PVA was prepared by hot-melt extrusion, and the pharmaceutical quality of the resulting properties of 3D printed PVA-based tablets for which
immediate drug release was expected was assessed by DoE (Cris
an et al. 2022).
,
The authors conducted a risk analysis to determine the quality of the resulting 3D
printed tablets and drew an Ishikawa diagram to explain the factors. In the study,
three factors (inner structure of tablet, tablet size, and layer height) were set, and
there were four parameters of output, drug contents, disintegration time, and amount
of drug dissolution at 5 and 10 min. D-optimal experimental design was adopted in
the DoE. The design spaces for tablets containing 30, 40, and 50 mg API, for which
more than 55% drug release was expected at 5 min and more than 80% drug release
at 10 min, were obtained.
3D printed polycaprolactone (PCL)-based implant containing dexamethasone
was prepared by FDM 3D printing (Dos Santos et al.
2021). In the study, 2
full factorial design containing three factors (the amount of drug, the amount of
mannitol, and the infill percentage) and two levels was used as the DoE. The
drug release constant and the time required to reach 10% and 20% were set as
the response. The multiple regression analysis equation indicated that the pore
former in the implant (i.e., water-soluble compounds such as mannitol) affected
the drug release, while infill percentage modulated drug release. In another study,
the influence of printing parameters on the resulting 3D printed placebo tablets
was investigated for three polymers (ABS, high-impact polystyrene, PLA) (Pires
et al.
2020). Results were collected for the printlet’s average mass, mass variation
coefficient, printing time, and porosity as a preliminary investigation.
DoE has been utilized for the production of polypills prepared using a PAM
3D printer (Alayoubi et al.
2022). Polypills were composed of a metoprolol-loaded
3
11 Machine Learning in Additive Manufacturing of Pharmaceuticals 363
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
core/shell compartment and an atorvastatin-loaded compartment. The authors varied
the amount of Carbopol loading in the core, HPMC loading in the shell, and
number of shell layers. The extrudability of drug formulations was assessed, and
data on several properties (flow pressure, compression rate, non-recoverable strain,
and elastic and plastic flow) were collected. The mechanical properties of the drug
formulation and 3D printed polypills were analyzed. Carbopol concentration in the
core affected the flow pressure and elastic/plastic flow ratio. Additionally, HPMC
affected the flow pressure due to its hydrogel property. The authors also provided
useful information about the extrudability of printer ink from a PAM 3D printer.
Pareto charts were provided on the influence of geometric and formulation variables
on drug dissolution. The number of shells and HPMC amount negatively affected
the drug release, whereas the void in atorvastatin-loaded 3D printed tablet positively
affected.
Zidan et al. focused on the rheological properties of printer ink to predict
its extrudability by PAM 3D printer (Zidan et al.
2019a, b). They prepared
printer ink composed of Carbopol, polyplasdone, microcrystalline cellulose, and
diclofenac. The printing pressure and viscoelastic properties were analyzed by a
texture analyzer and rheometer. The composition and nozzle diameter affected the
parameters of the Herschel-Bulkley equation, yielding stress, instantaneous elastic
displacement, and compression rate. The resulting response surface and contour plot
were obtained by DoE.
A binder jetting 3D printer was used for the preparation of ketoprofen-loaded
tablets (Kreft et al.
2022). In this study, designs containing five process parameters
were selected, and three responses (hardness, friability, and disintegration time)
were chosen. First, two level fractional factorial design was set as the screening
phase, and 11 experiments were conducted. Then D-optimal design was set, and
seven additional experiments were conducted for the optimization phase. The
influence of ink composition was also evaluated.
Madzarevic et al. conducted a study to predict drug release from 3D printed
tablets, and theirs was one of the key studies including both DoE and machine
learning (Madzarevic et al.
2019). 3D printed tablets were fabricated by DLP 3D
printing. Printer inks were composed of ibuprofen, PEGDA, PEG400, water, and
riboflavin as a photo-initiator. 3D printing was conducted by changing the exposure
time to light following the DoE. Physical and mechanical properties of tablets
including weight, diameter, thickness, hardness, and drug loading were determined.
The prediction of drug dissolution was conducted by D-optimal design, but the
authors concluded that the proposed mathematical model was not significant. They
also used two artificial neural networks with different hidden layers. Although
the machine learning model exhibited a high accuracy when predicting the drug
dissolution profile (R
2), the f
factor, which is an index of similarity of drug dissolution between the
2
2
= 0.9811, neural network 1; R2 = 0.9960, neural network
predicted and experimental results, was 52.15 for neural network 1 and 44.91 for
neural network 2. The same group investigated the effect of tablet thickness and
drug loading on the drug release from PEGDA-based tablets prepared by DLP 3D
364 T. Tagami et al.
printer (Stanojevi´cetal.2021). The application of a generalized regression neural
network could predict the release of atomoxetine.
11.6 Future Outlook: Artificial Intelligence (AI) Pharmacists
and 3D Printing Technology
In this section, we comment on the possible future roles of AI in pharmaceutical
work and the relationship with 3D printers as related to AI. The work of pharmacists
is becoming more digitalized: online pharmacies such as Amazon Pharmacy have
emerged, and the efficiency of pharmacist operations is improving. Many of the
tasks carried out by pharmacists in their work are routine tasks, and it is thought
that there are parts that could be easily completed by AI, but ultimately, it seems
ideal for human work and AI work to be carried out separately.
For example, a pharmacist dispenses a certain drug formulation when the
prescription is given by a doctor. There is a distinction between the work performed
by AI and the work performed by pharmacists, and it seems that AI could be in
charge of some simplified tasks, such as dispensing prescribed medications. On
the other hand, advanced skills that only humans can perform, such as observing
a patient’s facial expressions and attitude and receiving a patient’s detailed requests
by actually communicating with the patient and providing counseling, will likely
remain the work of human pharmacists. In addition, by having AI take charge of
some part of the work, it is conceivable that human pharmacists will be able to use
the extra time to develop other aspects of their job.
The effective use of AI has been mentioned in healthcare systems, and emerging
AI technology is expected to be implemented in hospitals and pharmacies for
(1) maintaining patients’ medical records, (2) helping with treatment decisionmaking, (3) assisting with repetitive tasks such as imaging (e.g., X-ray, computed
tomography scan), (4) providing medication-related health support, and (5) acting
as a total healthcare system incorporating personal data and information (Das et al.
2021).
The use of machine learning in healthcare may also require ethical considerations
(Chen et al.
pipeline stages: problem selection, data collection, outcome definition, algorithm
development, and post-development consideration. In the stages, the article mentions that the incautious use of machine learning may lead to injustices pertaining
to race, scientific workforce, gender, and global health. Although machine learning
may be used for medical decision-making and big data analysis for the method of
next generation, the algorithms may reflect unfair human biases (Char et al.
As the trained models in machine learning are considered a “black box,” it is hard to
address issues of transparency (Davenport and Kalakota
mistakes, it is difficult to pin responsibility on the AI.
If pharmaceutical manufacturing using 3D printers, which are related to AI, is
introduced to the medical field, it is conceivable that preparing custom-made drugs
by 3D printer could be one commercial application as well as that by dispensing
2021). The development of machine learning is separated into five
2018).
2019), and if an AI makes
11 Machine Learning in Additive Manufacturing of Pharmaceuticals 365
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Fig. 11.5 Future digital pharmacy where human pharmacist and artificial intelligence cooperate
together
robots (Fig. 11.5). Currently, compounding robots that dispense anticancer drugs
and robots that package pharmaceutical tablets are already on the market. The
automated compounding of chemotherapeutic ingredients can reduce compounding
errors and costs (Batson et al.
into
the manufacturing of custom-made pharmaceuticals. In addition, the concept of
a digital pharmacy using 3D printers has been proposed (Araújo et al.
e
xpected that the production of custom-made drugs using 3D printers, which was
2020). 3D printers are also expected to be incorporated
2019). It is
previously thought to be impossible due to complexity, will become possible with
AI technology.
11.7 Conclusions
Currently, the use of 3D printing technology in various medical fields is highly
anticipated, and research is being actively pursued in this area. 3D printers are
considered to be compatible with other digital technologies, and it is expected
that the development of custom-made drugs will be further promoted by fusing
technologies from different fields such as data science. Collaborating with other
fields outside of medicine can be expected to lead to the development of innovative
pharmaceuticals.
References
Aita IE, Rahman J, Breitkreutz J, Quodbach J (2020) 3D-printing with precise layer-wise
dose adjustments for paediatric use via pressure-assisted microsyringe printing. Eur J Pharm
Biopharm 157:59–65. https://doi.org/10.1016/j.ejpb.2020.09.012
Alayoubi A, Zidan A, Asfari S, Ashraf M, Sau L, Kopcha M (2022) Mechanistic understanding
the performance of personalized 3D-printed cardiovascular polypills: a case study of patient-
of
centered therapy. Int J Pharm 617:121599.
https://doi.org/10.1016/j.ijpharm.2022.121599
366 T. Tagami et al.
Anderspuk H, Viidik L, Olado K, Kogermann K, Juppo A, Heinämäki J, Laidmäe I (2021) Effects
of crosslinking on the physical solid-state and dissolution properties of 3D-printed theophylline
tablets. Ann 3D Print Med 4:100031. https://doi.org/10.1016/j.stlm.2021.100031
Arafat B, Qinna N, Cieszynska M, Forbes RT, Alhnan MA (2018) Tailored on demand anti-
coagulant
dosing: an in vitro and in vivo evaluation of 3D printed purpose-designed oral dosage
forms. Eur J Pharm Biopharm 128:282–289. https://doi.org/10.1016/j.ejpb.2018.04.010
Araújo MRP, Sa-Barreto LL, Gratieri T, Gelfuso GM, Cunha-Filho M (2019) The digital
pharmacies
era: how 3D printing technology using fused deposition modeling can become a
reality. Pharmaceutics 11:128. https://doi.org/10.3390/pharmaceutics11030128
Ayyoubi S, Cerda JR, Fernández-García R, Knief P, Lalatsa A, Healy AM, Serrano DR (2021)
printed spherical mini-tablets: geometry versus composition effects in controlling dissolu-
3D
tion from personalised solid dosage forms. Int J Pharm 597:120336. https://doi.org/10.1016/
j.ijpharm.2021.120336
Batson S, Mitchell SA, Lau D, Canobbio M, de Goede A, Singh I, Loesch U (2020) Automated
compounding
technology and workflow solutions for the preparation of chemotherapy: a
systematic review. Eur J Hosp Pharm 27:27. https://doi.org/10.1136/ejhpharm-2019-001948
Butler KT, Davies DW, Cartwright H, Isayev O, Walsh A (2018) Machine learning for molecular
materials science. Nature 559:547–555. https://doi.org/10.1038/s41586-018-0337-2
and
Castro BM, Elbadawi M, Ong JJ, Pollard T, Song Z, Gaisford S, Pérez G, Basit AW, Cabalar P,
yanes A (2021) Machine learning predicts 3D printing performance of over 900 drug delivery
Go
systems. J Control Release 337:530–545. https://doi.org/10.1016/j.jconrel.2021.07.046
Cerda JR, Arifi T, Ayyoubi S, Knief P, Ballesteros MP, Keeble W, Barbu E, Healy AM, Lalatsa
Serrano DR (2020) Personalised 3D printed medicines: optimising material properties for
A,
successful passive diffusion loading of filaments for fused deposition modelling of solid dosage
forms. Pharmaceutics 12:345. https://doi.org/10.3390/pharmaceutics12040345
Char DS, Shah NH, Magnus D (2018) Implementing machine learning in health care -addressing
challenges. N Engl J Med 378:981–983. https://doi.org/10.1056/NEJMp1714229
ethical
Chen IY, Pierson E, Rose S, Joshi S, Ferryman K, Ghassemi M (2021) Ethical machine learning in
healthcare.
Annu Rev Biomed 4:123–144. https://doi.org/10.1146/annurev-biodatasci-092820-
114757
an AG, Iurian S, Porfire A, Rus LM, Bogdan C, Casian T, Lucacel RC, Turza A,
Cris
,
Porav S, Tomut
˘
a I (2022) QbD guided development of immediate release FDM-3D printed
,
tablets with customizable API doses. Int J Pharm 613:121411. https://doi.org/10.1016/
j.ijpharm.2021.121411
Das S, Dey R, Nayak AK (2021) Artificial intelligence in pharmacy. Indian J Pharm Educ Res
55:304–318. https://doi.org/10.5530/ijper.55.2.68
Davenport T, Kalakota R (2019) The potential for artificial intelligence in healthcare. Future
J 6:94–98. https://doi.org/10.7861/futurehosp.6-2-94
Healthc
Delli U, Chang S (2018) Automated process monitoring in 3D printing using supervised machine
learning.
Procedia Manuf 26:865–870. https://doi.org/10.1016/j.promfg.2018.07.111
Dos Santos J, Deon M, da Silva GS, Beck RCR (2021) Multiple variable effects in the
customization
of fused deposition modelling 3D-printed medicine: a design of experiment
(DoE) approach. Inf J Pharm 597:120331. https://doi.org/10.1016/j.ijpharm.2021.120331
Elbadawi M, Muñiz Castro B, Gavins FKH, Ong JJ, Gaisford S, Pérez G, Basit AW, Cabalar P,
yanes A (2020a) M3DISEEN: a novel machine learning approach for predicting the 3D print-
Go
ability of medicines. Int J Pharm 590:119837. https://doi.org/10.1016/j.ijpharm.2020.119837
Elbadawi M, Gustaffson T, Gaisford S, Basit AW (2020b) 3D printing tablets: predicting
printability
and drug dissolution from rheological data. Int J Pharm 590:119868. https://doi.org/
10.1016/j.ijpharm.2020.119868
Galande AD, Khurana NA, Mutalik S (2020) Pediatric dosage forms—challenges and recent
velopments: a critical review. J Appl Pharm Sci 10:155–166. https://doi.org/10.7324/
de
APS.2020.10718
J
11 Machine Learning in Additive Manufacturing of Pharmaceuticals 367
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Goyanes A, Madla CM, Umerji A, Piñeiro GD, Montero JMG, Diaz MJL, Miguel Barcia G,
Taherali F, Sánchez-Pintos P, Couce ML, Gaisford S, Basit AW (2019) Automated therapy
preparation of isoleucine formulations using 3D printing for the treatment of MSUD: first
single-Centre, prospective, crossover study in patients. Int J Pharm 567:118497.
https://doi.org/
10.1016/j.ijpharm.2019.118497
Hamed R, Mohamed EM, Rahman Z, Khan MA (2021) 3D-printing of lopinavir printlets
selective laser sintering and quantification of crystalline fraction by XRPD-chemometric
by
models. Int J Pharm 592:120059. https://doi.org/10.1016/j.ijpharm.2020.120059
Han X, Kang D, Liu B, Zhang H, Wang Z, Gao X, Zheng A (2022) Feasibility of developing hospi-
preparation by semisolid extrusion 3D printing: personalized amlodipine besylate chewable
tal
tablets. Pharm Dev Technol 27:164–174.
https://doi.org/10.1080/10837450.2022.2027965
Henry S, Vadder LD, Decorte M, Francia S, Steenkiste MV, Saevels J, Vanhoorne V, Vervaet C
Development of a 3D-printed dosing platform to aid in zolpidem withdrawal therapy.
(2021)
Pharmaceutics 13:1684.
https://doi.org/10.3390/pharmaceutics13101684
Herrada-Manchón H, Rodríguez-González D, Fernández MA, Suñé-Pou M, Pérez-Lozano
, García-Montoya E (2020) Enrique Aguilar 53D printed gummies: personalized drug
P
dosage in a safe and appealing way. Int J Pharm 587:119687.
https://doi.org/10.1016/
j.ijpharm.2020.119687
Ilyas RA, Sapuan SM, Harussani MM, Hakimi MYAY, Haziq MZM, Atikah MSN, Asyraf MRM,
MR, Razman MR, Nurazzi NM, Norrrahim MNF, Abral H, Asrofi M (2021) Polylactic
Ishak
acid (PLA) biocomposite: processing, additive manufacturing and advanced applications.
Polymers 13:1326.
https://doi.org/10.3390/polym13081326
Jamróz W, Szafraniec J, Kurek M, Jachowicz R (2018) 3D printing in pharmaceutical
medical applications—recent achievements and challenges. Pharm Res 35:176.
and
link.springer
.com/article/10.1007/s11095-018-2454-x
https://
Jin Z, Zhang Z, Gu GX (2019) Autonomous in-situ correction of fused deposition modeling
using computer vision and deep learning. Manuf Lett 22:11–15.
printers
https://doi.org/10.1016/
j.mfglet.2019.09.005
Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ (2015) 3D printing of five-in-one dose
combination
217:308–314.
polypill with defined immediate and sustained release profiles. J Control Release
https://doi.org/10.1016/j.jconrel.2015.09.028
Khorasani M, Edinger M, Raijada D, Bøtker J, Aho J, Rantanen J (2016) Near-infrared chemical
imaging
(NIR-CI) of 3D printed pharmaceuticals. Int J Pharm 515:324–330.
https://doi.org/
10.1016/j.ijpharm.2016.09.075
Kreft K, LavriˇcZ
,Stani´c T, Perhavec P, Dreu R (2022) Influence of the binder jetting process
parameters and binder liquid composition on the relevant attributes of 3D-printed tablets.
Pharmaceutics 14:1568.
https://doi.org/10.3390/pharmaceutics14081568
Li Z, Zhang Z, Shi J, Wu D (2019) Prediction of surface roughness in extrusion-based additive
acturing with machine learning. Robot Comput Integr Manuf 57:488–495.
manuf
https://doi.org/
10.1016/j.rcim.2019.01.004
Macedo J, da Costa NF, Vanhoorne V, Vervaet C, Pinto JF (2022) The precision and accuracy of 3D
of tablets by fused deposition modelling. J Pharm Sci 111:2814–2826.
printing
https://doi.org/
10.1016/j.xphs.2022.05.006
Madzarevic M, Medarevic D, Vulovic A, Sustersic T, Djuris J, Filipovic N, Ibric S (2019)
Optimization
networks. Pharmaceutics 11:544.
and prediction of ibuprofen release from 3D DLP printlets using artificial neural
https://doi.org/10.3390/pharmaceutics11100544
Mahesh B (2020) Machine learning algorithms—a review. Int J Sci Res 9:381–386. https://
.ijsr.net/get_abstract.php?paper_id=ART20203995
www
Martinez PR, Goyanes A, Basit AW, Gaisford S (2018) Influence of geometry on the drug release
profiles
of stereolithographic (SLA) 3D-printed tablets. AAPS PharmSciTech 19:3355–3361.
https://link.springer.com/article/10.1208/s12249-018-1075-3
Melocchi A, Uboldi M, Maroni A, Foppoli A, Palugan L, Zema L, Gazzaniga A (2020) 3D
by fused deposition modeling of single- and multi-compartment hollow systems for oral
printing
delivery—a review. Int J Pharm 579:119155.
https://doi.org/10.1016/j.ijpharm.2020.119155
368 T. Tagami et al.
Meng L, McWilliams B, Jarosinski W, Park HY, Jung YG, Lee J, Zhang J (2020) Machine learning
in additive manufacturing: a review. JOM 72:2363–2377. https://doi.org/10.1007/s11837-020-
04155-y
Nasereddin JM, Wellner N, Alhijjaj M, Belton P, Qi S (2018) Development of a simple mechanical
screening
Pharm Res 35:151. https://link.springer.com/article/10.1007/s11095-018-2432-3#Sec1
Norman J, Madurawe RD, Moore CM, Khan MA, Khairuzzaman A (2017) A new chapter in
pharmaceutical
https://doi.org/10.1016/j.addr.2016.03.001
Öblom H, Sjöholm E, Rautamo M, Sandler N (2019) Towards printed pediatric medicines in
hospital
conventional oral powders in unit dose sachets. Pharmaceutics 11:334. https://doi.org/10.3390/
pharmaceutics11070334
Ong JJ, Castro BM, Gaisford S, Cabalar P, Basit AW, Pérez G, Goyanes A (2022) Accelerating 3D
printing
doi.or
Palekar S, Nukala PK, Mishra SM, Kipping T, Patel K (2019) Application of 3D printing technol-
ogy
of baclofen. Int J Pharm 556:106–116. https://doi.org/10.1016/j.ijpharm.2018.11.062
Pereira BC, Isreb A, Forbes RT, Dores F, Habashy R, Petit JB, Alhnan MA, Oga EF (2019)
‘T
cular ‘Polypill’ architectures. Eur J Pharm Biopharm 135:94–103. https://doi.org/10.1016/
j.ejpb
Pietrzak K, Isreb A, Alhnan MA (2015) A flexible-dose dispenser for immediate and extended
release
j.ejpb
Pires FQ, Alves-Silva I, Pinho LAG, Chaker JA, Sa-Barreto LL, Gelfuso GM, Gratieri T, Cunha-
Filho
pharmaceutical requirements for tablet production. Int J Pharm 588:119728. https://doi.org/
10.1016/j.ijpharm.2020.119728
Qi X, Chen G, Li Y, Cheng X, Li C (2019) Applying neural-network-based machine learning to
additi
5:721–729. https://doi.org/10.1016/j.eng.2019.04.012
Rycerz K, Stepien KA, Czapiewska M, Arafat BT, Habashy R, Isreb A, Peak A, Alhnan MA (2019)
Embedded
11:630. https://doi.org/10.3390/pharmaceutics11120630
Sadia M, Arafat B, Ahmed W, Forbes RT, Alhnan MA (2018) Channelled tablets: an innovative
approach
https://doi.org/10.1016/j.jconrel.2017.11.022
Samaro A, Shaqour B, Goudarzi NM, Ghijs M, Cardon L, Boone MN, Verleije B, Beyers
K,
feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using
extrusion-based additive manufacturing? Int J Pharm 6-7:120922. https://doi.org/10.1016/
j.ijpharm.2021.120922
Sarabi MR, Alseed MM, Karagoz AA, Tasoglu S (2022) Machine learning-enabled prediction of
3D-printed
Scoutaris N, Ross SA, Douroumis D (2018) D Printed “starmix” drug loaded dosage forms
for
017-2284-2
Stanojevi´c
release rate from DLP 3D-printed tablets using artificial neural networks: influence of tablet
thickness and drug loading. Molecules 26:111. https://doi.org/10.3390/molecules26010111
method for predicting the feedability of a pharmaceutical FDM 3D printing filament.
manufacturing: 3D-printed drug products. Adv Drug Deliv Rev 108:39–50.
pharmacies: comparison of 2D and 3D-printed orodispersible warfarin films with
of pharmaceutical products using machine learning. Int J Pharm X 4:100120. https://
g/10.1016/j.ijpx.2022.100120
and quality by design approach for development of age-appropriate pediatric formulation
emporary Plasticiser’: a novel solution to fabricate 3D printed patient-centred cardiovas-
.2018.12.009
3D printed tablets. Eur J Pharm Biopharm 96:380–387. https://doi.org/10.1016/
.2015.07.027
M (2020) Predictive models of FDM 3D printing using experimental design based on
ve manufacturing: current applications, challenges, and future perspectives. Engineering
3D printing of novel bespoke soft dosage form concept for pediatrics. Pharmaceutics
to accelerating drug release from 3D printed tablets. J Control Release 269:355–363.
Vanhoorne V, Cos P, Vervaet C (2021) Can filaments, pellets and powder be used as
microneedle features. Biosensors 12:491. https://doi.org/10.3390/bios12070491
paediatric applications. Pharm Res 35:34. https://link.springer.com/article/10.1007/s11095-
G, Medarevi´c D, Adamov I, Peši´cN,Kovaˇcevi´cJ,Ibri´c S (2021) Tailoring atomoxetine
11 Machine Learning in Additive Manufacturing of Pharmaceuticals 369
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Tabriz AG, Scoutaris N, Gong Y, Hui HW, Kumar S, Douroumis D (2021) Investigation on hot
melt extrusion and prediction on 3D printability of pharmaceutical grade polymers. Int J Pharm
604:120755. https://doi.org/10.1016/j.ijpharm.2021.120755
Tagami T, Kuwata E, Sakai N, Ozeki T (2019) Drug incorporation into polymer filament using
soaking method for tablet preparation using fused deposition modeling. Biol Pharm Bull
simple
42:1753–1760.
https://doi.org/10.1248/bpb.b19-00482
Tagami T, Ito E, Kida R, Hirose K, Noda T, Ozeki T (2021a) 3D printing of gummy drug
formulations
594:120118.
composed of gelatin and an HPMC-based hydrogel for pediatric use. Int J Pharm
https://doi.org/10.1016/j.ijpharm.2020.120118
Tagami T, Morimura C, Ozeki T (2021b) Effective and simple prediction model of drug release
“ghost tablets” fabricated using a digital light projection-type 3D printer. Int J Pharm
from
604:120721.
https://doi.org/10.1016/j.ijpharm.2021.120721
Trenfield SJ, Goyanes A, Telford R, Wilsdon D, Rowland M, Gaisford S, Basit AD (2018) 3D
drug products: non-destructive dose verification using a rapid point-and-shoot approach.
printed
Int J Pharm 549:283–292.
https://doi.org/10.1016/j.ijpharm.2018.08.002
Trenfield SJ, Awad A, Madla CM, Hatton GB, Firth J, Goyanes A, Gaisford S, Basit AW (2019)
the future: recent advances of 3D printing in drug delivery and healthcare. Expert Opin
Shaping
Drug Deliv 16:1081–1094.
https://doi.org/10.1080/17425247.2019.1660318
Trenfield SJ, Tan HX, Goyanes A, Wilsdon D, Rowland M, Gaisford S, Basit AW (2020)
Non-destructi
577:119066.
ve dose verification of two drugs within 3D printed polyprintlets. Int J Pharm
https://doi.org/10.1016/j.ijpharm.2020.119066
Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, Li B, Madabhushi A, Shah P,
M, Zhao S (2019) Applications of machine learning in drug discovery and development.
Spitzer
Nat Rev Drug Discov 18:463–477.
https://doi.org/10.1038/s41573-019-0024-5
Vo AQ, Zhang J, Nyavanandi D, Bandari S, Repka MA (2020) Hot melt extrusion paired fused
deposition
cinnarizine. Carbohydr Polym 246:116519.
modeling 3D printing to develop hydroxypropyl cellulose based floating tablets of
https://doi.org/10.1016/j.carbpol.2020.116519
Walsh D, Serrano DR, Worku ZA, Norris BA, Healy AM (2018) Production of cocrystals
an excipient matrix by spray drying. Int J Pharm 536:467–477.
in
https://doi.org/10.1016/
j.ijpharm.2017.12.020
Wang Z, Li J, Hong X, Han X, Liu B, Li X, Zhang H, Gao J, Liu N, Gao X, Zheng A (2021) Taste
study based on an electronic tongue: the formulation design of 3D printed levetiracetam
masking
instant-dissolving tablets. Pharm Res 38:831–842.
https://link.springer.com/article/10.1007/
s11095-021-03041-9
Zhu C, Tian Y, Zhang E, Gao X, Zhang H, Liu N, Han X, Sun Y, Wang Z, Zheng A (2022)
Semisolid
extrusion 3D printing of propranolol hydrochloride gummy chewable tablets: an
innovative approach to prepare personalized medicine for pediatrics. AAPS PharmSciTech
https://link.springer.com/article/10.1208/s12249-022-02304-x
23:166.
Zidan A, Alayoubi A, Coburn J, Asfari S, Ghammraoui B, Cruz CN, Ashraf M (2019a)
Extrudability
Pharm 554:292–301.
analysis of drug loaded pastes for 3D printing of modified release tablets. Int J
https://doi.org/10.1016/j.ijpharm.2018.11.025
Zidan A, Alayoubi A, Asfari S, Coburn J, Ghammraoui B, Aqueel S, Cruz CN, Ashraf M (2019b)
velopment of mechanistic models to identify critical formulation and process variables of
De
pastes for 3D printing of modified release tablets. Int J Pharm 555:109–123.
https://doi.org/
10.1016/j.ijpharm.2018.11.044
Соседние файлы в папке Библиотека им академика М.И. Перельмана